212 related articles for article (PubMed ID: 38396644)
21. Computed tomography, magnetic resonance imaging, and positron emission tomography/computed tomography findings for the diagnosis of malignant struma ovarii: A case report.
Yamauchi S; Kokabu T; Kataoka H; Yoriki K; Takahata A; Mori T
J Obstet Gynaecol Res; 2023 May; 49(5):1456-1461. PubMed ID: 36808795
[TBL] [Abstract][Full Text] [Related]
22. A single nucleotide polymorphism associated with isolated cleft lip and palate, thyroid cancer and hypothyroidism alters the activity of an oral epithelium and thyroid enhancer near FOXE1.
Lidral AC; Liu H; Bullard SA; Bonde G; Machida J; Visel A; Uribe LM; Li X; Amendt B; Cornell RA
Hum Mol Genet; 2015 Jul; 24(14):3895-907. PubMed ID: 25652407
[TBL] [Abstract][Full Text] [Related]
23. Struma Ovarii with a focus of follicular variant of papillary thyroid cancer: a case report.
Lao M; Koike J; Chauhan S; Schiano M; Plata M
W V Med J; 2008; 104(4):12-4. PubMed ID: 18646677
[TBL] [Abstract][Full Text] [Related]
24. Editorial on: Role of gene sequencing in classifying struma ovarii: BRAF P.G469A mutation and TERT promoter alterations favour malignant struma ovarii.
McCluggage WG
Histopathology; 2024 Jan; 84(2):288-290. PubMed ID: 38110823
[No Abstract] [Full Text] [Related]
25. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
26. Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studies.
Ciccarelli A; Valdes-Socin H; Parma J; Khoo SK; Schoumans J; Colao A; Hamoir E; Beckers A
Eur J Endocrinol; 2004 Apr; 150(4):431-7. PubMed ID: 15080771
[TBL] [Abstract][Full Text] [Related]
27. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
28. Malignant struma ovarii. A case report and review of the literature.
Berghella V; Ngadiman S; Rosenberg H; Hoda S; Zuna RE
Gynecol Obstet Invest; 1997; 43(1):68-72. PubMed ID: 9015705
[TBL] [Abstract][Full Text] [Related]
29. Expression of thyroid transcription factor 1 (TTF-1) in extra thyroidal sites: papillary thyroid carcinoma of branchial cleft cysts and thyroglossal duct cysts and struma ovarii.
Lanzafame S; Caltabiano R; Puzzo L; Immè A
Pathologica; 2006 Dec; 98(6):640-4. PubMed ID: 17285841
[TBL] [Abstract][Full Text] [Related]
30. Malignant struma ovarii: surgical, histopathological and survival outcomes for thyroid-type carcinoma of struma ovarii with recommendations for standardising multi-modal management. A retrospective case series sharing the experience of a single institution over 10 years.
Addley S; Mihai R; Alazzam M; Dhar S; Soleymani Majd H
Arch Gynecol Obstet; 2021 Apr; 303(4):863-870. PubMed ID: 33512594
[TBL] [Abstract][Full Text] [Related]
31. Pathology of Struma Ovarii: A Report of 96 Cases.
Wei S; Baloch ZW; LiVolsi VA
Endocr Pathol; 2015 Dec; 26(4):342-8. PubMed ID: 26374222
[TBL] [Abstract][Full Text] [Related]
32. Synchronous Independent Papillary Thyroid Carcinomas in Struma Ovarii and the Thyroid Gland With Different
Gomes-Lima CJ; Nikiforov YE; Lee W; Burman KD
J Endocr Soc; 2018 Aug; 2(8):944-948. PubMed ID: 30087949
[TBL] [Abstract][Full Text] [Related]
33. Papillary thyroid cancer in a struma ovarii: a report of a rare case.
Monti E; Mortara L; Zupo S; Dono M; Minuto F; Truini M; Naseri M; Giusti M
Hormones (Athens); 2015; 14(1):154-9. PubMed ID: 25402391
[TBL] [Abstract][Full Text] [Related]
34. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases.
Devaney K; Snyder R; Norris HJ; Tavassoli FA
Int J Gynecol Pathol; 1993 Oct; 12(4):333-43. PubMed ID: 8253550
[TBL] [Abstract][Full Text] [Related]
35. An unusual variant of malignant struma ovarii.
Amalaseelan JV; Perera KA
Ceylon Med J; 2008 Jun; 53(2):55-6. PubMed ID: 18678124
[TBL] [Abstract][Full Text] [Related]
36. Malignant struma ovarii--a case report and review of the literature.
Hatami M; Breining D; Owers RL; Del Priore G; Goldberg GL
Gynecol Obstet Invest; 2008; 65(2):104-7. PubMed ID: 17890867
[TBL] [Abstract][Full Text] [Related]
37. Papillary type thyroid carcinoma in an ovarian struma.
O'Neill JP; Burns P; Kinsella J
Ir J Med Sci; 2012 Mar; 181(1):115-7. PubMed ID: 20339953
[TBL] [Abstract][Full Text] [Related]
38. Malignant struma ovarii: report of a case and review of the literature.
Kostoglou-Athanassiou I; Lekka-Katsouli I; Gogou L; Papagrigoriou L; Chatonides I; Kaldrymides P
Horm Res; 2002; 58(1):34-8. PubMed ID: 12169779
[TBL] [Abstract][Full Text] [Related]
39. A novel FOXE1 mutation (R73S) in Bamforth-Lazarus syndrome causing increased thyroidal gene expression.
Carré A; Hamza RT; Kariyawasam D; Guillot L; Teissier R; Tron E; Castanet M; Dupuy C; El Kholy M; Polak M
Thyroid; 2014 Apr; 24(4):649-54. PubMed ID: 24219130
[TBL] [Abstract][Full Text] [Related]
40. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer.
Wolff EF; Hughes M; Merino MJ; Reynolds JC; Davis JL; Cochran CS; Celi FS
Thyroid; 2010 Sep; 20(9):981-7. PubMed ID: 20718682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
